Mersine A Bryan1,2, Arti D Desai3,2, Lauren Wilson3, Davene R Wright3,2, Rita Mangione-Smith3,2. 1. Department of Pediatrics, University of Washington, Seattle, Washington; and mersine@uw.edu. 2. Center for Child Health, Behavior and Development, Seattle Children's Research Institute, Seattle, Washington. 3. Department of Pediatrics, University of Washington, Seattle, Washington; and.
Abstract
OBJECTIVES: To examine the associations between the level of adherence to bronchiolitis clinical pathway recommendations, health care use, and costs. METHODS: We conducted a retrospective cohort study of 267 patients ≤24 months old diagnosed with bronchiolitis from 12/2009 to 7/2012. Clinical pathway adherence was assessed by using a standardized scoring system (0-100) for 18 quality measures obtained by medical record review. Level of adherence was categorized into low, middle, and high tertiles. Generalized linear models were used to examine relationships between adherence tertile and (1) length of stay (LOS) and (2) costs. Logistic regression was used to examine the associations between adherence tertile and probability of inpatient admission and 7-day readmissions. RESULTS: Mean adherence scores were: ED, 78.8 (SD, 18.1; n = 264), inpatient, 95.0 (SD, 6.3; n = 216), and combined ED/inpatient, 89.1 (SD, 8.1; n = 213). LOS was significantly shorter for cases in the highest versus the lowest adherence tertile (ED, 90 vs 140 minutes, adjusted difference, -51 [95% confidence interval (CI), -73 to -29; P <.05]; inpatient, 3.1 vs 3.8 days, adjusted difference, -0.7 [95% CI, -1.4 to 0.0; P <.05]). Costs were less for cases in the highest adherence tertile (ED, -$84, [95% CI, -$7 to -$161; P <.05], total, -$1296 [95% CI, -126.43 to -2466.03; P <.05]). ED cases in the highest tertile had a lower odds of admission (odds ratio, 0.38 [95% CI, 0.15-0.97; P < .05]). Readmissions did not differ by tertile. CONCLUSIONS: High adherence to bronchiolitis clinical pathway recommendations across care settings was associated with shorter LOS and lower cost.
OBJECTIVES: To examine the associations between the level of adherence to bronchiolitis clinical pathway recommendations, health care use, and costs. METHODS: We conducted a retrospective cohort study of 267 patients ≤24 months old diagnosed with bronchiolitis from 12/2009 to 7/2012. Clinical pathway adherence was assessed by using a standardized scoring system (0-100) for 18 quality measures obtained by medical record review. Level of adherence was categorized into low, middle, and high tertiles. Generalized linear models were used to examine relationships between adherence tertile and (1) length of stay (LOS) and (2) costs. Logistic regression was used to examine the associations between adherence tertile and probability of inpatient admission and 7-day readmissions. RESULTS: Mean adherence scores were: ED, 78.8 (SD, 18.1; n = 264), inpatient, 95.0 (SD, 6.3; n = 216), and combined ED/inpatient, 89.1 (SD, 8.1; n = 213). LOS was significantly shorter for cases in the highest versus the lowest adherence tertile (ED, 90 vs 140 minutes, adjusted difference, -51 [95% confidence interval (CI), -73 to -29; P <.05]; inpatient, 3.1 vs 3.8 days, adjusted difference, -0.7 [95% CI, -1.4 to 0.0; P <.05]). Costs were less for cases in the highest adherence tertile (ED, -$84, [95% CI, -$7 to -$161; P <.05], total, -$1296 [95% CI, -126.43 to -2466.03; P <.05]). ED cases in the highest tertile had a lower odds of admission (odds ratio, 0.38 [95% CI, 0.15-0.97; P < .05]). Readmissions did not differ by tertile. CONCLUSIONS: High adherence to bronchiolitis clinical pathway recommendations across care settings was associated with shorter LOS and lower cost.
Authors: Perseus V Patel; Matthew S Pantell; Melvin B Heyman; Sofia Verstraete Journal: J Pediatr Gastroenterol Nutr Date: 2019-11 Impact factor: 2.839
Authors: Rita Mangione-Smith; Chuan Zhou; Derek J Williams; David P Johnson; Chén C Kenyon; Amy Tyler; Ricardo Quinonez; Joyee Vachani; Julie McGalliard; Joel S Tieder; Tamara D Simon; Karen M Wilson Journal: Pediatrics Date: 2019-08 Impact factor: 7.124
Authors: Timothy J D Ohlsen; Alexander M Knudson; E Kent Korgenski; David R Sandweiss; Michelle G Hofmann; Tiffany S Glasgow; Eric R Coon Journal: J Hosp Med Date: 2021-05 Impact factor: 2.960
Authors: Edward L Barnes; Bharati Kochar; Millie D Long; Christopher F Martin; Michael D Kappelman Journal: Inflamm Bowel Dis Date: 2017-12 Impact factor: 7.290
Authors: Louise K Wiles; Tamara D Hooper; Peter D Hibbert; Charlotte Molloy; Les White; Adam Jaffe; Christopher T Cowell; Mark F Harris; William B Runciman; Annette Schmiede; Chris Dalton; Andrew R Hallahan; Sarah Dalton; Helena Williams; Gavin Wheaton; Elisabeth Murphy; Jeffrey Braithwaite Journal: PLoS One Date: 2019-01-09 Impact factor: 3.240